190884756	190884756	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
16418951	16418951	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1804931	1804931	CD	B-NP	O
|	|	CC	I-NP	O
3/8/2004	3/8/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPTIC	SEPTIC	NNP	I-NP	I-protein
KNEE	KNEE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/20/2004	6/20/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/17/2004	9/17/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
RAFAEL	RAFAEL	NNP	B-NP	O
WASKO	WASKO	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Admitted	Admitted	NNP	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Septic	Septic	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
and	and	CC	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
hemophilia	hemophilia	NN	I-NP	O
,	,	,	O	O
HCV	HCV	NN	B-NP	O
with	with	IN	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
,	,	,	O	O
HIV	HIV	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
infections	infection	NNS	I-NP	O
including	include	VBG	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
endocarditis	endocarditis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
hip	hip	NN	B-NP	O
replacement	replacement	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
painful	painful	JJ	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
prosthetic	prosthetic	JJ	I-NP	O
joint	joint	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
septic	septic	JJ	I-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
rehab	rehab	NN	I-NP	O
therapy	therapy	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
twisted	twist	VBD	B-VP	O
his	his	PRP$	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
gave	give	VBD	B-VP	O
him	him	PRP	B-NP	O
some	some	DT	B-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intervening	intervening	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
become	become	VBN	I-VP	O
more	more	RBR	B-ADJP	O
painful	painful	JJ	I-ADJP	O
,	,	,	I-ADJP	O
red	red	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
swollen	swollen	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
without	without	IN	B-PP	O
great	great	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
where	where	WRB	B-ADVP	O
as	as	IN	B-SBAR	O
before	before	IN	I-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
tolerating	tolerate	VBG	I-VP	O
rehab	rehab	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
to	to	TO	B-PP	O
103.0	103.0	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
dialysis	dialysis	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
worsen	worsen	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
restriction	restriction	NN	I-NP	O
in	in	IN	B-PP	O
range	range	NN	B-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
reported	report	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
infected	infected	JJ	I-NP	O
knee	knee	NN	I-NP	O
versus	versus	IN	B-PP	O
hemarthrosis	hemarthrosis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reported	report	VBD	B-VP	O
some	some	DT	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
chills	chill	NNS	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	I-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
months	month	NNS	I-NP	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
paracentesis	paracentesis	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
weekly	weekly	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
taken	take	VBN	B-VP	O
off	off	RP	B-PRT	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
hematology	hematology	NN	I-NP	O
fellow	fellow	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
knee	knee	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
tapped	tap	VBN	I-VP	O
by	by	IN	B-PP	O
Orthopedics	Orthopedics	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
only	only	RB	B-NP	O
some	some	DT	I-NP	O
dark	dark	JJ	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dialysis	dialysis	NN	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hemophilia	Hemophilia	NN	B-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
virus	virus	NN	I-NP	O
with	with	IN	B-PP	O
cirrhosis	cirrhosis	NN	B-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HIV	HIV	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
endocarditis	endocarditis	NN	I-NP	O
,	,	,	O	O
MSSA	MSSA	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
hip	hip	NN	B-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Nafcillin	Nafcillin	NN	B-NP	B-protein
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Included	Include	VBN	B-NP	O
Epogen	Epogen	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
mitogen	mitogen	NN	B-NP	B-protein
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
Neutra-Phos	Neutra-Phos	NN	B-NP	O
,	,	,	O	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
,	,	,	I-NP	O
Carnitor	Carnitor	NNP	I-NP	O
,	,	,	I-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
q.	q.	NN	I-NP	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
Carafate	Carafate	NNP	B-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
Amphojel	Amphojel	NNP	B-NP	O
,	,	,	O	O
Compazine	Compazine	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
five	five	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
HIV	HIV	NN	B-NP	O
and	and	CC	I-NP	O
HCV	HCV	NN	I-NP	B-protein
from	from	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
currently	currently	RB	B-ADVP	O
working	work	VBG	B-VP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
deficiency	deficiency	NN	I-NP	O
hemophilia	hemophilia	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
slight	slight	JJ	I-NP	O
tachycardiac	tachycardiac	NN	I-NP	O
at	at	IN	B-PP	O
105	105	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
normotensive	normotensive	JJ	B-ADJP	O
at	at	IN	B-PP	O
120/72	120/72	CD	B-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
cachetic	cachetic	JJ	B-ADJP	O
and	and	CC	O	O
chronically	chronically	RB	B-ADJP	O
ill	ill	JJ	I-ADJP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
comfortable	comfortable	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
veins	vein	NNS	I-NP	O
were	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
,	,	,	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
flank	flank	NN	B-NP	O
dullness	dullness	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
port	port	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
being	be	VBG	B-VP	O
wasted	waste	VBN	I-VP	O
,	,	,	O	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
absent	absent	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
knee	knee	NN	I-NP	O
was	be	VBD	B-VP	O
erythematous	erythematous	JJ	B-ADJP	O
,	,	,	O	O
edematous	edematous	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
extremely	extremely	RB	B-ADJP	O
tender	tender	NN	I-ADJP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.2	5.2	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
4.2	4.2	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
10.4	10.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.6	36.6	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
332	332	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PT	PT	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
15.4	15.4	CD	B-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
62.3	62.3	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

X-ray	X-ray	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
left	left	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
erythrocyte	erythrocyte	NN	I-NP	O
sedimentation	sedimentation	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
70	70	CD	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
8/22/04	8/22/04	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
incision	incision	NN	I-NP	O
and	and	CC	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Moelter	Moelter	NNP	I-NP	O
of	of	IN	B-PP	O
Orthopedics	Orthopedics	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/20/04	10/20/04	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hemodialysis-tunneled	hemodialysis-tunneled	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBN	B-VP	O
by	by	IN	B-PP	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
2/7/04	2/7/04	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-NP	O
and	and	CC	I-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
septic	septic	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
prosthetic	prosthetic	JJ	I-NP	O
joint	joint	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
methicillin-sensitive	methicillin-sensitive	JJ	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
aureus	aureus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
organism	organism	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
caused	cause	VBN	I-VP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
endocarditis	endocarditis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
incision	incision	NN	B-NP	O
and	and	CC	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
by	by	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Majka	Majka	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
8/22/04	8/22/04	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
on	on	IN	B-PP	O
10/15/04	10/15/04	CD	B-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
too	too	RB	B-ADVP	O
had	have	VBD	B-VP	O
grown	grow	VBN	I-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MSSA	MSSA	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
positive	positive	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
once	once	IN	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
1/4	1/4	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
coag-negative	coag-negative	JJ	B-NP	O
Staph	Staph	NN	I-NP	O
from	from	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
contamination	contamination	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
just	just	RB	B-ADVP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
#	#	#	B-NP	O
14	14	CD	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
low-grade	low-grade	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
temperature	temperature	NN	I-NP	O
spiked	spike	VBD	B-VP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
Orthopedics	Orthopedics	NNP	B-NP	O
and	and	CC	O	O
Infectious	Infectious	NNP	B-NP	O
Disease	Disease	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
followed	follow	VBD	B-VP	O
him	him	PRP	B-NP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
and	and	CC	O	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
consultant	consultant	NN	I-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
became	become	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
after	after	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
joint	joint	JJ	B-NP	O
exploitation	exploitation	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
negative	negative	JJ	I-NP	O
culture	culture	NN	I-NP	O
this	this	DT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
occur	occur	VB	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
prosthetic	prosthetic	JJ	B-NP	O
joint	joint	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
joint	joint	JJ	I-NP	B-cell_line
fluid	fluid	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
as	as	RB	B-NP	O
well	well	RB	I-NP	O
synovial	synovial	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
synovial	synovial	JJ	B-NP	O
culture	culture	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
I	I	NNP	I-NP	I-DNA
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MSSA	MSSA	NN	B-NP	B-protein
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
six-week	six-week	JJ	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
for	for	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
by	by	IN	B-PP	O
Orthopedics	Orthopedic	NNS	B-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
his	his	PRP$	B-NP	O
sutures	suture	NNS	I-NP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Glader	Glader	NNP	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
symptom	symptom	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
deficiency	deficiency	NN	I-NP	O
hemophilia	hemophilia	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
normally	normally	RB	B-ADVP	O
takes	take	VBZ	B-VP	O
q.	q.	NN	B-NP	O
week	week	NN	I-NP	O
or	or	CC	B-NP	O
twice	twice	RB	I-NP	O
weekly	weekly	JJ	I-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
before	before	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
for	for	IN	B-PP	O
arthrocentesis	arthrocentesis	NN	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
4000	4000	CD	I-NP	O
units	unit	NNS	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
situation	situation	NN	I-NP	O
regarding	regard	VBG	B-VP	O
surgery	surgery	NN	B-NP	O
and	and	CC	I-NP	O
line	line	NN	I-NP	O
placement	placement	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
b.i.d.	b.i.d.	JJ	B-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_line
last	last	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
before	before	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
only	only	RB	B-ADVP	O
upon	upon	IN	B-PP	O
return	return	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tutson	Tutson	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
hematologist	hematologist	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
Mondays	Monday	NNS	I-NP	O
,	,	,	O	O
Wednesdays	Wednesday	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Fridays	Friday	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
temporary	temporary	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
artery	artery	NN	I-NP	O
catheter	catheter	NN	I-NP	O
and	and	CC	O	O
only	only	RB	B-ADVP	O
as	as	IN	B-SBAR	O
clinically	clinically	RB	B-ADVP	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
on	on	IN	B-PP	O
10/20/04	10/20/04	CD	B-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
home	home	NN	I-NP	I-DNA
renal	renal	JJ	I-NP	I-DNA
supplements	supplement	NNS	I-NP	I-DNA
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
and	and	CC	I-NP	O
midodrine	midodrine	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
HCV	HCV	NN	B-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
occult	occult	JJ	I-NP	O
blood	blood	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
additionally	additionally	RB	B-ADVP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
or	or	CC	I-NP	O
SPP	SPP	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taped	tap	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
port	port	NN	I-NP	O
thrice	thrice	NN	I-NP	O
weekly	weekly	RB	B-ADVP	O
with	with	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
culture	culture	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
upper	upper	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
diabetes	diabetes	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
some	some	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
300s	300s	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
Regular	Regular	JJ	I-NP	O
Insulin	Insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
added	add	VBN	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
despite	despite	IN	B-PP	O
his	his	PRP$	B-NP	O
immobility	immobility	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
hemophilia	hemophilia	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
TED	TED	VBN	B-NP	O
hose	hose	NN	I-NP	O
and	and	CC	I-NP	O
pneumoboots	pneumoboot	NNS	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
low	low	JJ	I-NP	O
albumin	albumin	NN	I-NP	O
and	and	CC	O	O
general	general	JJ	B-NP	O
cachexia	cachexia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1.5	1.5	CD	I-NP	O
liters	liter	NNS	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
g	g	NN	I-NP	O
sodium	sodium	NN	I-NP	O
restriction	restriction	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
ascites	ascite	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
supplementing	supplement	VBG	I-VP	O
with	with	IN	B-PP	O
Enlive	Enlive	NNP	B-NP	O
and	and	CC	I-NP	O
Ensure	Ensure	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
adequate	adequate	JJ	B-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
new	new	JJ	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ezequiel	Ezequiel	NNP	I-NP	O
Strawn	Strawn	NNP	I-NP	O
,	,	,	O	O
Orthopedics	Orthopedics	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
by	by	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
hematologist	hematologist	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
renal	renal	JJ	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Bibasilar	Bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
on	on	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Distended	Distend	VBN	B-VP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
abdomen	abdoman	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
clean	clean	JJ	I-NP	O
suture	suture	JJ	I-NP	O
line	line	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
warmth	warmth	NN	I-NP	O
,	,	,	I-NP	O
erythema	erythema	NN	I-NP	O
or	or	CC	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
Amphojel	Amphojel	NNP	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
one-half	one-half	JJ	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
on	on	IN	B-PP	O
Sundays	Sunday	NNS	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-VP	O
q.	q.	VB	I-VP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
finished	finish	VBN	I-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
,	,	,	O	O
Flexeril	Flexeril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
muscle	muscle	NN	B-NP	O
spasms	spasm	NNS	I-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
coverage	coverage	NN	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
25	25	CD	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
125	125	CD	B-NP	O
to	to	TO	I-NP	O
150	150	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
151	151	CD	B-ADVP	O
to	to	TO	I-ADVP	O
200	200	CD	I-ADVP	O
,	,	,	O	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
201	201	CD	B-ADVP	O
to	to	TO	I-ADVP	O
250	250	CD	I-ADVP	O
,	,	,	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
251-300	251-300	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
301-350	301-350	CD	B-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
351-400	351-400	CD	B-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
notify	notify	VBP	B-VP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
to	to	TO	B-VP	O
titrate	titrate	VB	I-VP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
Neutra-Phos	Neutra-Phos	NNP	B-NP	O
two	two	CD	I-NP	O
packets	packet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
simethicone	simethicone	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
,	,	,	O	O
Carafate	Carafate	NNP	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
redosed	redose	VBN	I-VP	O
for	for	IN	B-PP	O
levels	level	NNS	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
finished	finish	VBN	I-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
,	,	,	O	O
Compazine	Compazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
groin	groin	NN	I-NP	O
,	,	,	O	O
Carnitor	Carnitor	NN	B-NP	O
0.5	0.5	CD	I-NP	O
g	g	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
midodrine	midodrine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
one	one	CD	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
esomeprazole	esomeprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
chewable	chewable	JJ	B-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Epogen	Epogen	NN	B-NP	O
4000	4000	CD	I-NP	O
units	unit	NNS	I-NP	O
q.	q.	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
Nixry	Nixry	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
call	call	NN	B-NP	O
190-417-1134	190-417-1134	CD	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Royal	Royal	NNP	I-NP	O
Tartsah	Tartsah	NNP	I-NP	O
at	at	IN	B-PP	O
Mecrant	Mecrant	NNP	B-NP	O
Win	Win	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
on	on	IN	B-PP	O
3/10/04	3/10/04	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pujol	Pujol	NNP	I-NP	O
of	of	IN	B-PP	O
Hematology	Hematology	NNP	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sturmer	Sturmer	NNP	I-NP	O
of	of	IN	B-PP	O
Orthopedics	Orthopedics	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
by	by	IN	B-PP	O
return	return	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
FOR	FOR	IN	B-PP	O
REHABILITATION	REHABILITATION	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
until	until	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
redosed	redose	VBN	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
level	level	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
to	to	TO	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
after	after	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
is	be	VBZ	B-VP	O
finished	finish	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
paracentesis	paracentesis	NN	B-NP	O
on	on	IN	B-PP	O
Tuesdays	Tuesday	NNS	B-NP	O
,	,	,	O	O
Thursdays	Thursday	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Saturdays	Saturday	NNS	B-NP	O
via	via	IN	B-PP	O
port	port	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
as	as	IN	B-SBAR	O
dictated	dictate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
suture	suture	JJ	B-NP	O
removal	removal	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
operation	operation	NN	I-NP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
sterile	sterile	JJ	I-NP	O
dressing	dress	VBG	I-NP	O
change	change	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
Mononine	Mononine	NN	I-NP	O
50	50	CD	B-NP	O
units	unit	NNS	I-NP	O
per	per	IN	B-PP	O
kg	kg	NN	B-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
dialysis	dialysis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
PMD	PMD	NN	I-NP	O
,	,	,	O	O
Renal	Renal	NNP	B-NP	O
,	,	,	O	O
Hematology	Hematology	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Orthopedics	Orthopedics	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
Enlive	Enlive	NNP	B-NP	O
b.i.d.	b.i.d.	VB	B-VP	O
and	and	CC	I-VP	O
Ensure	Ensure	VB	I-VP	O
q.d.	q.d.	RB	B-ADVP	O
as	as	IN	B-PP	O
nutritional	nutritional	JJ	B-NP	O
supplements	supplement	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
on	on	IN	B-PP	O
2/7/04	2/7/04	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
good	good	JJ	B-NP	O
position	position	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-9426766	0-9426766	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Derick	Derick	NNP	B-NP	O
Garland	Garland	NNP	I-NP	O
Loseke	Loseke	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
ERGLI	ERGLI	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
Iviale	Iviale	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Cortez	Cortez	NNP	B-NP	O
Wipfli	Wipfli	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Jeffro	Jeffro	NNP	I-NP	O
Buba	Buba	NNP	I-NP	O
Caen	Caen	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Lakeel	Lakeel	NNP	I-NP	O
Houwayne	Houwayne	NNP	I-NP	O
Green	Green	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MAJOCKA	MAJOCKA	NNP	B-NP	O
,	,	,	O	O
WERNER	WERNER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MOHD	MOHD	NN	B-NP	O
,	,	,	O	O
ERROL	ERROL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7820828	7820828	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/7/04	2/7/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/7/04	2/7/04	CD	B-NP	O

